Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3770266014 | Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3770267017 | Product containing precisely anthraquinone glycoside 5 milligram/1 milliliter and salicylic acid 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution | Has manufactured dose form | Oromucosal solution | true | Inferred relationship | Some | ||
| Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
| Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 2 | |
| Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
| Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
| Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution | Is a | Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution | Has precise active ingredient | Salicylic acid (substance) | true | Inferred relationship | Some | 1 | |
| Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution | Has precise active ingredient | Anthraquinone glycoside (substance) | true | Inferred relationship | Some | 2 | |
| Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution | Has basis of strength substance (attribute) | Anthraquinone glycoside (substance) | true | Inferred relationship | Some | 2 | |
| Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution | Has basis of strength substance (attribute) | Salicylic acid (substance) | true | Inferred relationship | Some | 1 | |
| Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution | Has concentration strength numerator value | 5 | false | Inferred relationship | Some | 2 | |
| Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution | Has concentration strength numerator value | 10 | false | Inferred relationship | Some | 1 | |
| Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution | Plays role | Antifungal therapeutic role (role) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR